UNSPSC 51282119: Hetacillin

This classification denotes a penicillin antibiotic with the molecular formula C19H23N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TN4JSC48CV, chemically known as 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)penicillansaeure but generally known as hetacillin, which bears US NIH Compound Identifier 3596. European Medicines Agency schedules Hetacillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08020MIG. The term HETACILLIN is an International Non-Proprietary Name.

UNSPSC 51282119 Hetacillin, a Commodity code, shows minimal recent state and local procurement activity. The two opportunities on record are both misaligned with hetacillin itself — one is a completed piggyback award for antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) through the Illinois Department of Public Health, and the other is Seminole County, Florida's solicitation for Naloxone and drug deactivation systems. Neither opportunity involves hetacillin procurement. The code's nominal scope — hetacillin, a broad-spectrum beta-lactam antibiotic — does not align with what state and local governments are actually buying under this classification in the recent record.

The Illinois opportunity, awarded August 28, 2026, was an IFB through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC for a 12-month initial term with two renewal options at $2,999,999.11 total contract value. The Seminole County opportunity, posted June 30, 2026 with a July 26, 2026 response deadline, was an IFB for quarterly deliveries of naloxone and deactivation systems. Beyond these two records, the code reflects no substantive state or local procurement signal. Business development professionals should verify whether hetacillin itself appears in recent state or local health-department solicitations before allocating pursuit resources to this code; the current data suggests limited or mislabeled activity.